www.fgks.org   »   [go: up one dir, main page]

Jump to content

Cold sensitive antibodies: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
→‎Cold agglutinin antibodies: // Edit via Wikiplus
Citation bot (talk | contribs)
Add: doi-access. | Use this bot. Report bugs. | #UCB_CommandLine
 
(37 intermediate revisions by 21 users not shown)
Line 1: Line 1:
{{Infobox medical condition (new)
{{Infobox medical condition (new)
| name = {{PAGENAME}}
| name = Cold sensitive antibodies
| synonyms = Cold reactive antibodies, cold reacting antibodies
| synonyms = Cold reactive antibodies, cold reacting antibodies
| image =
| image =
| width =
| width =
| alt =
| alt =
| caption =
| caption =
| pronounce =
| pronounce =
| specialty = [[Hematology]]
| specialty = [[Hematology]]
| symptoms =
| symptoms =
Line 12: Line 12:
| >
| >
| duration =
| duration =
| types =
| types =
| causes =
| causes =
| risks =
| risks =
| diagnosis =
| diagnosis =
| differential =
| differential =
Line 22: Line 22:
| prognosis =
| prognosis =
| frequency =
| frequency =
| deaths =
| deaths =
}}
}}


'''Cold sensitive antibodies''' ('''CSA''') are [[antibodies]] sensitive to cold temperature. Some cold sensitive antibodies are pathological and can lead to [[blood disorder]]. These pathological cold sensitive antibodies include [[cold agglutinins]], [[Dnotath-Landsteniner antibodies]], and [[cryoglobulins]] which are the culprits of [[cold agglutinin disease]], [[paroxysmal cold hemoglobinuria]] in the process of [[Donath-Landsteiner hemolytic anemia]], and [[vasculitis]], respectively.
'''Cold sensitive antibodies''' ('''CSA''') are [[antibodies]] sensitive to cold temperature. Some cold sensitive antibodies are pathological and can lead to [[blood disorder]]. These pathological cold sensitive antibodies include [[cold agglutinins]], [[Donath–Landsteiner antibodies]], and [[cryoglobulins]] which are the culprits of [[cold agglutinin disease]], [[paroxysmal cold hemoglobinuria]] in the process of [[Donath–Landsteiner hemolytic anemia]], and [[vasculitis]], respectively.


==Cold agglutinin antibodies==
==Cold agglutinin antibodies==


Cold agglutinins are [[antibodies]], typically [[immunoglobulin M]] ([[IgM]]), that are acquainted with and then binding the antigens on red blood cells, typically [[Ii antigen system|antigens "I" or "i"]] on the RBC surface<ref name="Pascual Victor Spellerberg Hamblin pp. 2337–44">{{cite journal | last=Pascual | first=V | last2=Victor | first2=K | last3=Spellerberg | first3=M | last4=Hamblin | first4=TJ | last5=Stevenson | first5=FK | last6=Capra | first6=JD | title=VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. | journal=Journal of immunology (Baltimore, Md. : 1950) | volume=149 | issue=7 | date=1992-10-01 | issn=0022-1767 | pmid=1382098 | pages=2337–44}}</ref>, in the environment in which the temperatures are lower than normal core body temperature and, thus, ends up leading to [[extravascular hemolysis|agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels]] (extra-vessels}, resulting in anemia without [[hemoglobinuria]] in ordinary cases<ref name="Berentsen 2018 pp. 320–330">{{cite journal | last=Berentsen | first=Sigbjørn | title=How I manage patients with cold agglutinin disease | journal=British journal of haematology | publisher=Wiley | volume=181 | issue=3 | date=2018-01-24 | issn=0007-1048 | pmid=29363757 | doi=10.1111/bjh.15109 | pages=320–330}}</ref>.
Cold agglutinins are [[antibodies]], typically [[immunoglobulin M]] ([[IgM]]), that are acquainted with and then binding the antigens on red blood cells, typically [[Ii antigen system|antigens "I" or "i"]] on the RBC surface,<ref name="Pascual Victor Spellerberg Hamblin pp. 2337–44">{{cite journal | last1=Pascual | first1=V | last2=Victor | first2=K | last3=Spellerberg | first3=M | last4=Hamblin | first4=TJ | last5=Stevenson | first5=FK | last6=Capra | first6=JD | title=VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities. | journal=Journal of Immunology | volume=149 | issue=7 | date=1992-10-01 | issn=0022-1767 | pmid=1382098 | pages=2337–44| doi=10.4049/jimmunol.149.7.2337 | s2cid=29186107 | doi-access=free }}</ref> in the environment in which the temperatures are lower than normal core body temperature and, thus, ends up leading to [[extravascular hemolysis|agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels]] (extra-vessels), resulting in anemia without [[hemoglobinuria]] in ordinary cases.<ref name="Berentsen 2018 pp. 320–330">{{cite journal | last=Berentsen | first=Sigbjørn | title=How I manage patients with cold agglutinin disease | journal=British Journal of Haematology | publisher=Wiley | volume=181 | issue=3 | date=2018-01-24 | issn=0007-1048 | pmid=29363757 | doi=10.1111/bjh.15109 | pages=320–330| doi-access=free }}</ref>


Cold agglutinins can cause two pathological conditions, that are, [[primary cold agglutinin disease]] (CAD)<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842">{{cite journal | last=Małecka | first=Agnieszka | last2=Trøen | first2=Gunhild | last3=Tierens | first3=Anne | last4=Østlie | first4=Ingunn | last5=Małecki | first5=Jędrzej | last6=Randen | first6=Ulla | last7=Wang | first7=Junbai | last8=Berentsen | first8=Sigbjørn | last9=Tjønnfjord | first9=Geir E. | last10=Delabie | first10=Jan M. A. | title=Frequent somatic mutations of KMT 2D ( MLL 2 ) and CARD 11 genes in primary cold agglutinin disease | journal=British journal of haematology | publisher=Wiley | volume=183 | issue=5 | date=19 December 2017 | issn=0007-1048 | pmid=29265349 | doi=10.1111/bjh.15063 | pages=838–842}}</ref> and [[secondary cold agglutinin syndrome]] (CAS)<ref name="Berentsen 2018 pp. 320–330"/>, both of which are sole two subtypes of [[cold agglutinin disease]].
Cold agglutinins can cause two pathological conditions, that are, primary cold agglutinin disease (CAD)<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842">{{cite journal | last1=Małecka | first1=Agnieszka | last2=Trøen | first2=Gunhild | last3=Tierens | first3=Anne | last4=Østlie | first4=Ingunn | last5=Małecki | first5=Jędrzej | last6=Randen | first6=Ulla | last7=Wang | first7=Junbai | last8=Berentsen | first8=Sigbjørn | last9=Tjønnfjord | first9=Geir E. | last10=Delabie | first10=Jan M. A. | title=Frequent somatic mutations of KMT 2D ( MLL 2 ) and CARD 11 genes in primary cold agglutinin disease | journal=British Journal of Haematology | publisher=Wiley | volume=183 | issue=5 | date=19 December 2017 | issn=0007-1048 | pmid=29265349 | doi=10.1111/bjh.15063 | pages=838–842| doi-access=free }}</ref> and secondary cold agglutinin syndrome (CAS),<ref name="Berentsen 2018 pp. 320–330"/> both of which are sole two subtypes of [[cold agglutinin disease]].


Primary cold agglutinin disease is idiopathic, meaning the phenomenons of agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels are absent from any underlying cause<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842"/>. Nevertheless, what is known is, those with idiopathic cold agglutinin disease are susceptible to having or developing mild [[clonal bone marrow disorder]]<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842"/>.
Primary cold agglutinin disease is idiopathic, meaning the phenomenons of agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels are absent from any underlying cause.<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842"/> Nevertheless, what is known is, those with idiopathic cold agglutinin disease are susceptible to having or developing mild [[clonal bone marrow disorder]].<ref name="Małecka Trøen Tierens Østlie 2018 pp. 838–842"/>


Secondary cold agglutinin syndrome refers to cold agglutinin disease that is identified to be caused by [[viral infection]], [[autoimmune disorder]], [[lymphoid malignancy]], or any other underlying disease.<ref name="Randen Troen Tierens Steen 2014 pp. 497–504">{{cite journal | last=Randen | first=U. | last2=Troen | first2=G. | last3=Tierens | first3=A. | last4=Steen | first4=C. | last5=Warsame | first5=A. | last6=Beiske | first6=K. | last7=Tjonnfjord | first7=G. E. | last8=Berentsen | first8=S. | last9=Delabie | first9=J. | title=Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma | journal=Haematologica | publisher=Ferrata Storti Foundation (Haematologica) | volume=99 | issue=3 | date=18 October 2013 | issn=0390-6078 | pmid=24143001 | pmc=3943313 | doi=10.3324/haematol.2013.091702 | pages=497–504}}</ref>
Secondary cold agglutinin syndrome refers to cold agglutinin disease that is identified to be caused by [[viral infection]], [[autoimmune disorder]], [[lymphoid malignancy]], or any other underlying disease.<ref name="Randen Troen Tierens Steen 2014 pp. 497–504">{{cite journal | last1=Randen | first1=U. | last2=Troen | first2=G. | last3=Tierens | first3=A. | last4=Steen | first4=C. | last5=Warsame | first5=A. | last6=Beiske | first6=K. | last7=Tjonnfjord | first7=G. E. | last8=Berentsen | first8=S. | last9=Delabie | first9=J. | title=Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma | journal=Haematologica | publisher=Ferrata Storti Foundation (Haematologica) | volume=99 | issue=3 | date=18 October 2013 | issn=0390-6078 | pmid=24143001 | pmc=3943313 | doi=10.3324/haematol.2013.091702 | pages=497–504}}</ref>


===Thermal amplitude===
===Thermal amplitude===
Cold agglutinins (CA) are autoantibodies that agglutinate RBCs with a temperature optimum of 3-4°C but may also act in a warmer environment, depending on the [[thermal amplitude]] of the CA. If the thermal amplitude exceeds 28–30°C, the CA will be pathogenic. Low-affinity CA also occurs in many healthy individuals; these nonpathogenic CA are [[polyclonal]], have low thermal amplitude, and are present in low [[titer]]s, not higher than 256 and usually lower than 64. More than 90% of pathogenic CA are of the IgM class and these IgM macromolecules can be [[pentameric]] or [[hexameric]].<ref name="Berentsen Sundic 2015 pp. 1–11">{{cite journal | last=Berentsen | first=Sigbjørn | last2=Sundic | first2=Tatjana | title=Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy | journal=BioMed Research International | publisher=Hindawi Limited | volume=2015 | date=2015-01-29 | issn=2314-6133 | pmid=25705656 | pmc=4326213 | doi=10.1155/2015/363278 | pages=1–11 | type={{CC-PMC}}}}</ref>
Cold agglutinins (CA) are autoantibodies that agglutinate RBCs with a temperature optimum of 3-4&nbsp;°C but may also act in a warmer environment, depending on the [[Thermal amplitude (medical)|thermal amplitude]] of the CA. If the thermal amplitude exceeds 28–30&nbsp;°C, the CA will be pathogenic. Low-[[Chemical affinity|affinity]] CA also occurs in many healthy individuals; these nonpathogenic CA are [[polyclonal]], have low thermal amplitude, and are present in low [[titer]]s, not higher than 256 and usually lower than 64. More than 90% of pathogenic CA are of the IgM class and these IgM macromolecules can be [[pentameric]] or [[hexameric]].<ref name="Berentsen Sundic 2015 pp. 1–11">{{cite journal | last1=Berentsen | first1=Sigbjørn | last2=Sundic | first2=Tatjana | title=Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy | journal=BioMed Research International | publisher=Hindawi Limited | volume=2015 | date=2015-01-29 | issn=2314-6133 | pmid=25705656 | pmc=4326213 | doi=10.1155/2015/363278 | pages=363278| doi-access=free }}</ref>


==Donath-Landsteiner antibodies==
==Donath–Landsteiner antibodies==


Donath-Landsteiner antibodies share similarities with cold agglutinin disease in recognition and connection of the antigens on the red blood cells' surface in the presence of relatively lower temperatures compared to core body temperature. Yet, the place where the hemolysis taking place differentiates between {{nowrap|D-L}} antibodies and cold agglutinin. <ref name="Silberstein Berkman Schreiber 1987 pp. 238–42">{{cite journal | last=Silberstein | first=LE | last2=Berkman | first2=EM | last3=Schreiber | first3=AD | title=Cold hemagglutinin disease associated with IgG cold-reactive antibody. | journal=Annals of internal medicine | volume=106 | issue=2 | year=1987 | issn=0003-4819 | pmid=3800184 | pages=238–42}}</ref><ref name="Rosse Adams 1980 pp. 409–16">{{cite journal | last=Rosse | first=WF | last2=Adams | first2=JP | title=The variability of hemolysis in the cold agglutinin syndrome. | journal=Blood | volume=56 | issue=3 | year=1980 | issn=0006-4971 | pmid=7407408 | pages=409–16}}</ref><ref name="Zilow Kirschfink Roelcke 1994 pp. 410–5">{{cite journal | last=Zilow | first=G | last2=Kirschfink | first2=M | last3=Roelcke | first3=D | title=Red cell destruction in cold agglutinin disease. | journal=Infusionstherapie und Transfusionsmedizin | volume=21 | issue=6 | year=1994 | issn=1019-8466 | pmid=7873920 | pages=410–5}}</ref> D-L antibodies rather fix [[complement system]] which result in hemolysis in vessels (intra-vessels). [[Blood vessel]]s are pathways carrying living-required elements to reach everywhere inside the body through circulation. This explains why the clinical manifestations of hemolysis caused by D-L antibodies are in line with representations of [[hemoglobinemia]] and [[hemoglobinuria]]. D-L antibodies, typically [[IgG]], are characterized by targeting against red blood cells' on-surface [[P_antigen_system|antigens called "P"]]. <ref name="Medscape Reference 2019 on d-l">{{cite web | title=Donath-Landsteiner Hemolytic Anemia: Practice Essentials, Pathophysiology, Etiology | website=Medscape Reference | date=2019-02-02 | url=https://emedicine.medscape.com/article/955176-overview | access-date=2019-02-11 | author=Trisha Simone Tavares}}</ref><ref name="Barcellini 2015 pp. 3–5">{{cite | last=Barcellini | first=W | title=Pitfalls in the diagnosis of autoimmune haemolytic anaemia. | journal=Blood transfusion = Trasfusione del sangue | volume=13 | issue=1 | year=2015 | issn=1723-2007 | pmid=25636128 | pmc=4317084 | doi=10.2450/2014.0252-14 | pages=3–5}}</ref>
Donath–Landsteiner antibodies share similarities with cold agglutinin disease in recognition and connection of the antigens on the red blood cells' surface in the presence of relatively lower temperatures compared to core body temperature. Yet, the place where the hemolysis taking place differentiates between {{nowrap|D-L}} antibodies and cold agglutinin.<ref name="Silberstein Berkman Schreiber 1987 pp. 238–42">{{cite journal | last1=Silberstein | first1=LE | last2=Berkman | first2=EM | last3=Schreiber | first3=AD | title=Cold hemagglutinin disease associated with IgG cold-reactive antibody. | journal=Annals of Internal Medicine | volume=106 | issue=2 | year=1987 | issn=0003-4819 | pmid=3800184 | pages=238–42| doi=10.7326/0003-4819-106-2-238 }}</ref><ref name="Rosse Adams 1980 pp. 409–16">{{cite journal | last1=Rosse | first1=WF | last2=Adams | first2=JP | title=The variability of hemolysis in the cold agglutinin syndrome. | journal=Blood | volume=56 | issue=3 | year=1980 | issn=0006-4971 | pmid=7407408 | pages=409–16 | doi=10.1182/blood.v56.3.409.bloodjournal563409| doi-access=free }}</ref><ref name="Zilow Kirschfink Roelcke 1994 pp. 410–5">{{cite journal | last1=Zilow | first1=G | last2=Kirschfink | first2=M | last3=Roelcke | first3=D | title=Red cell destruction in cold agglutinin disease. | journal=Infusionstherapie und Transfusionsmedizin | volume=21 | issue=6 | year=1994 | issn=1019-8466 | pmid=7873920 | pages=410–5 | doi=10.1159/000223021}}</ref> D-L antibodies rather fix [[complement system]] which result in [[intravascular hemolysis|hemolysis in vessels]] (intra-vessels). [[Blood vessel]]s are pathways carrying living-required elements to reach everywhere inside the body through circulation. This explains why the clinical manifestations of hemolysis caused by D-L antibodies are in line with representations of [[hemoglobinemia]] and [[hemoglobinuria]]. D-L antibodies, typically [[Immunoglobulin G|IgG]], are characterized by targeting against red blood cells' on-surface [[P antigen system|antigens called "P"]].<ref name="Medscape Reference 2019 on d-l">{{cite journal | title=Donath-Landsteiner Hemolytic Anemia: Practice Essentials, Pathophysiology, Etiology | website=Medscape Reference | date=2019-02-02 | url=https://emedicine.medscape.com/article/955176-overview | access-date=2019-02-11 | author=Trisha Simone Tavares}}</ref><ref name="Barcellini 2015 pp. 3–5">{{citation | last=Barcellini | first=W | title=Pitfalls in the diagnosis of autoimmune haemolytic anaemia. | journal=Blood Transfusion = Trasfusione del Sangue | volume=13 | issue=1 | year=2015 | issn=1723-2007 | pmid=25636128 | pmc=4317084 | doi=10.2450/2014.0252-14 | pages=3–5}}</ref>


The [[pathophysiology]] of [[Donath-Landsteiner hemolytic anemia]] has been entitled as [[paroxysmal cold hemoglobinuria]].
The [[pathophysiology]] of [[Donath–Landsteiner hemolytic anemia]] has been entitled as [[paroxysmal cold hemoglobinuria]].{{cn|date=November 2021}}

===Thermal amplitude===


==Cryoglobulins antibodies==
==Cryoglobulins antibodies==


Cryoglobulins are abnormal antibodies that only dissolve/disappear at temperature higher than {{convert|37|C|F}} and form solid or gel-like immune complexes in presence of the environment under {{convert|37|C|F}}<ref name="MedlinePlus 2019">{{cite web | title=Cryoglobulins: MedlinePlus Medical Encyclopedia | website=MedlinePlus | date=2019-01-28 | url=https://medlineplus.gov/ency/article/003555.htm | access-date=2019-02-13}}</ref><ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015">{{cite web | title=Cold agglutinin disease | website=Genetic and Rare Diseases Information Center (GARD) – an NCATS Program | date=2015-09-11 | url=https://rarediseases.info.nih.gov/diseases/6130/cold-agglutinin-disease/cases/33623 | access-date=2019-02-13 | others= {{PD-notice}}}}</ref>, which can block blood vessels and cause a variety of health problems<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/> including inflammation and organ damage<ref name="Ferri Zignego Pileri 2002 pp. 4–13">{{cite journal | last=Ferri | first=C | last2=Zignego | first2=AL | last3=Pileri | first3=SA | title=Cryoglobulins | journal=Journal of Clinical Pathology | volume=55 | issue=1 | year=2002 | pmid=11825916 | pmc=1769573 | pages=4–13}}</ref><ref name="Cleveland Clinic">{{cite web | title=Cryoglobulinemia | website=Cleveland Clinic | url=https://my.clevelandclinic.org/health/diseases/13204-cryoglobulinemia | access-date=2019-02-13}}</ref>.
Cryoglobulins are abnormal antibodies that only dissolve/disappear at temperature higher than {{convert|37|C|F}} and form solid or gel-like immune complexes in presence of the environment under {{convert|37|C|F}},<ref name="MedlinePlus 2019">{{cite web | title=Cryoglobulins: MedlinePlus Medical Encyclopedia | website=MedlinePlus | date=2019-01-28 | url=https://medlineplus.gov/ency/article/003555.htm | access-date=2019-02-13}}</ref><ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015">{{cite web | title=Cold agglutinin disease | website=Genetic and Rare Diseases Information Center (GARD) – an NCATS Program | date=2015-09-11 | url=https://rarediseases.info.nih.gov/diseases/6130/cold-agglutinin-disease/cases/33623 | access-date=2019-02-13 | archive-date=2019-03-30 | archive-url=https://web.archive.org/web/20190330143532/https://rarediseases.info.nih.gov/diseases/6130/cold-agglutinin-disease/cases/33623 | url-status=dead }}</ref> which can block blood vessels and cause a variety of health problems<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/> including inflammation and organ damage.<ref name="Ferri Zignego Pileri 2002 pp. 4–13">{{cite journal | last1=Ferri | first1=C | last2=Zignego | first2=AL | last3=Pileri | first3=SA | title=Cryoglobulins | journal=Journal of Clinical Pathology | volume=55 | issue=1 | year=2002 | pmid=11825916 | pmc=1769573 | pages=4–13| doi=10.1136/jcp.55.1.4 }}</ref><ref name="Cleveland Clinic">{{cite web | title=Cryoglobulinemia | website=Cleveland Clinic | url=https://my.clevelandclinic.org/health/diseases/13204-cryoglobulinemia | access-date=2019-02-13}}</ref>


Many people affected by cryoglobulins will not experience any unusual signs or symptoms. When present, symptoms vary but may include [[breathing problem]]s; [[fatigue]]; [[glomerulonephritis]]; [[joint pain]] or [[muscle pain]]; [[purpura]]; [[Raynaud's phenomenon]]; [[skin death]]; and/or [[skin ulcer]]s. In some cases, the exact underlying cause is unknown; however, cryoglobulinemia can be associated with a variety of conditions including certain types of infection; chronic inflammatory diseases (such as autoimmune disease); and/or cancers of the blood or immune system. Treatment varies based on the severity of the condition, the symptoms present in each person and the underlying cause<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/>.
Many people affected by cryoglobulins will not experience any unusual signs or symptoms. When present, symptoms vary but may include [[breathing problem]]s; [[fatigue]]; [[glomerulonephritis]]; [[joint pain]] or [[muscle pain]]; [[purpura]]; [[Raynaud's phenomenon]]; [[skin death]]; and/or [[skin ulcer]]s. In some cases, the exact underlying cause is unknown; however, cryoglobulinemia can be associated with a variety of conditions including certain types of infection; chronic inflammatory diseases (such as autoimmune disease); and/or cancers of the blood or immune system. Treatment varies based on the severity of the condition, the symptoms present in each person and the underlying cause.<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/>


At least 90% of cases having cryoglobulins in body, [[hepatitis C]] is to blame<ref name="MedlinePlus 2019"/><ref name="Ferri Zignego Pileri 2002 pp. 4–13"/>, reflecting the importance of preclusion of hepatitis C<ref name="MedlinePlus 2019"/><ref name="Ferri Zignego Pileri 2002 pp. 4–13"/>. The presence of cryoglubulins in body satisfies the criterion of the diagnosis of [[cryoglobulinemia]], a disease that [[vasculitis|inflame the blood vessels]] and organs like kidney, nerves, joints, lungs and skin<ref name="MedlinePlus 2019"/>. Normally, there are no cryoglobulins should be found in the body<ref name="MedlinePlus 2019"/>.
At least 90% of cases having cryoglobulins in body, [[hepatitis C]] is to blame,<ref name="MedlinePlus 2019"/><ref name="Ferri Zignego Pileri 2002 pp. 4–13"/> reflecting the importance of preclusion of hepatitis C.<ref name="MedlinePlus 2019"/><ref name="Ferri Zignego Pileri 2002 pp. 4–13"/> The presence of cryoglobulins in body satisfies the criterion of the diagnosis of [[cryoglobulinemia]], a disease that [[vasculitis|inflame the blood vessels]] and organs like kidney, nerves, joints, lungs and skin.<ref name="MedlinePlus 2019"/> Normally, no cryoglobulins should be found in the body.<ref name="MedlinePlus 2019"/>


Cryoglobulins more than often do not interact with red blood cells, unless it combines the features of cold agglutinin with cryoglobulins, although the chance is deemed rare. Therefore, cryoglobulins don't produce hemolysis effect, however its serious [[Complication (medicine)|complication]]s such as [[systemic inflammatory response syndrome|systemic inflammatory]] or neoplastic disorders can in turn lead to anemia<ref name="Ferri Zignego Pileri 2002 pp. 4–13"/>.
Cryoglobulins more than often do not interact with red blood cells, unless it combines the features of cold agglutinin with cryoglobulins, although the chance is deemed rare. Therefore, cryoglobulins don't produce hemolysis effect, however its serious [[Complication (medicine)|complication]]s such as [[systemic inflammatory response syndrome|systemic inflammatory]] or neoplastic disorders can in turn lead to anemia.<ref name="Ferri Zignego Pileri 2002 pp. 4–13"/>


== Comparisons between cold agglutinin, Donath–Landsteiner antibodies and cryoglobulin ==
===Thermal amplitude===

==Comparisons between cryoglobulin, cold agglutinin and Donath-Landsteiner antibodies==

Although there is some overlap of symptoms, cryoglobulinemia and cold agglutinin disease differ in the process by which blood vessels become blocked<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/>. In cryoglobulinemia, antibodies accumulate and block blood vessels<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/><ref name="MedlinePlus 2019 s">{{cite web | title=Cryoglobulinemia: MedlinePlus Medical Encyclopedia | website=MedlinePlus | date=2019-01-28 | url=https://medlineplus.gov/ency/article/000540.htm | access-date=2019-02-13}}</ref>. In cold agglutinin disease, antibodies (different from those in cryoglobulinemia) attack and kill red blood cells, which then accumulate and [[blood vessel blockage|block blood vessels]]<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/><ref name="Medscape Reference 2019">{{cite web | title=Cold Agglutinin Disease: Practice Essentials, Pathophysiology, Etiology | website=Medscape Reference | date=2019-02-02 | url=https://emedicine.medscape.com/article/135327-overview | access-date=2019-02-13}}</ref>.

Three types of pathological cold sensitive antibodies can all trigger [[Raynaud's phenomenon]]. <ref name="Gaddy p=468">{{cite journal | last=Gaddy | first=Clifford G. | title=Raynaud's Syndrome Associated with Idiopathic Cryoglobulinemia and Cold Agglutinins | journal=Archives of Internal Medicine | publisher=American Medical Association (AMA) | volume=102 | issue=3 | date=1958-09-01 | issn=0003-9926 | doi=10.1001/archinte.1958.00030010468020 | page=468}}</ref><ref name="Mitchell Pergrum Gill 1974 pp. 113–5">{{cite journal | last=Mitchell | first=AB | last2=Pergrum | first2=GD | last3=Gill | first3=AM | title=Cold agglutinin disease with Raynaud's phenomenon. | journal=Proceedings of the Royal Society of Medicine | volume=67 | issue=2 | year=1974 | issn=0035-9157 | pmid=4544972 | pmc=1645247 | pages=113–5}}</ref><ref name="Antinuclear antibodies">{{cite journal| journal=Annals of the Rheumatic Diseases | date= 1982 | volume= 41 | pages= 382-387 | title=Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | author1=C. G. M. KALLENBERG |author2=G. W. PASTOOR |author3=A. A. WOUDA |author4=T. H. THE | url=https://web.archive.org/web/20190214101520/https://ard.bmj.com/content/annrheumdis/41/4/382.full.pdf}}</ref><ref name="Lodi Resca Reverberi p. ">{{cite journal | last=Lodi | first=Gianluca | last2=Resca | first2=Daniela | last3=Reverberi | first3=Roberto | title=Fatal cold agglutinin-induced haemolytic anaemia: a case report | journal=Journal of Medical Case Reports | publisher=Springer Nature | volume=4 | issue=1 | date=2010-08-06 | issn=1752-1947 | doi=10.1186/1752-1947-4-252 | page=}}</ref><ref name="Gertz pp. 19–23">{{cite journal | last=Gertz | first=M. A. | title=Cold Hemolytic Syndrome | journal=Hematology | publisher=American Society of Hematology | volume=2006 | issue=1 | date=2006-01-01 | issn=1520-4391 | doi=10.1182/asheducation-2006.1.19 | pages=19–23}}</ref><ref>{{cite journal| title=Two Different Serologic Mechanisms of Paroxysmal Cold Hemoglobinuria, Illustrated by Three Cases | author1= J. J. VAN LOGHEM, Jn. |author2=E. MENDES DE LEON, M.D. |author3=HERTA FRENKEL-TIETZ, |author4=IIA VAN DER HART | url=https://web.archive.org/web/20190214102320/http://www.bloodjournal.org/content/bloodjournal/7/12/1196.full.pdf?sso-checked=true | date=1952}}</ref>

Three types of pathological cold antibodies can all be ''[[acquired]]'' <ref name=" 1956 pp. 221–40">{{cite journal | last=WIENER | first= AS | last2=UNGER | first2= LJ | last3=COHEN | first3= L | last4=FELDMAN | first4= J | title=Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions: biologic test with bovine red cells. | journal=Annals of internal medicine | volume=44 | issue=2 | year=1956 | issn=0003-4819 | pmid=13292836 | pages=221–40}}</ref><ref name="Mehrotra 1960 pp. 265–271">{{cite journal | last=Mehrotra | first=TN | title=Immunological Identification of the Pathological Cold Auto-Antibodies of Acquired Haemolytic Anaemia as β2M-Globulin | journal=Immunology | volume=3 | issue=3 | year=1960 | pmid= | pmc=1424011 | pages=265–271}}</ref><ref>[https://www.webmd.com/a-to-z-guides/autoimmune-hemolytic-anemia Acquired Autoimmune Hemolytic Anemia]</ref><ref name="Allgood Chaplin 1967 pp. 254–73">{{cite journal | last=Allgood | first=JW | last2=Chaplin | first2=H Jr | title=Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. | journal=The American journal of medicine | volume=43 | issue=2 | year=1967 | issn=0002-9343 | pmid=6034957 | pages=254–73}}</ref>.

===Composition===


Although there is some overlap of symptoms, cryoglobulinemia and cold agglutinin disease differ in the process by which blood vessels become blocked.<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/> In cryoglobulinemia, antibodies accumulate and block blood vessels.<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/><ref name="MedlinePlus 2019 s">{{cite web | title=Cryoglobulinemia: MedlinePlus Medical Encyclopedia | website=MedlinePlus | date=2019-01-28 | url=https://medlineplus.gov/ency/article/000540.htm | access-date=2019-02-13}}</ref> In cold agglutinin disease, antibodies (different from those in cryoglobulinemia) attack and kill red blood cells, which then accumulate and [[vascular occlusion|block blood vessels]].<ref name="Genetic and Rare Diseases Information Center (GARD) – an NCATS Program 2015"/><ref name="Medscape Reference 2019">{{cite journal | title=Cold Agglutinin Disease: Practice Essentials, Pathophysiology, Etiology | website=Medscape Reference | date=2019-02-02 | url=https://emedicine.medscape.com/article/135327-overview | access-date=2019-02-13}}</ref>
{| class="wikitable"
{| class="wikitable"
|+
!
!Cold agglutinin antibodies<ref name="UpToDate" />
!Donath–Landsteiner antibodies<ref name=UpToDate>{{cite web|url=https://ykhoa.org/d/image.htm?imageKey=HEME/103370|title=Comparison of paroxysmal cold hemoglobinuria, cold agglutinin disease, and cryoglobulinemia|website=UpToDate|accessdate=2023-05-01}}</ref>
!Cryoglobulin<ref name=UpToDate/>
|-
|-
|Associated disease
! Type
|[[Cold agglutinin disease]]
! Composition
|[[Paroxysmal cold hemoglobinuria]]
! Percent of cases
|[[Cryoglobulinemia]]<ref name="Ferri2002">{{cite journal |vauthors = Ferri C, Zignego AL, Pileri SA |title = Cryoglobulins |journal = J. Clin. Pathol. |volume = 55 |issue = 1 |pages = 4–13 |year = 2002 |pmid = 11825916 |doi = 10.1136/jcp.55.1.4 |pmc = 1769573 }}</ref>
! Association with other diseases
|-
|-
|Typical antibody types
| Type I
|[[IgM]]
| [[Monoclonal]] IgG, IgM, IgA, or [[Immunoglobulin light chain|their κ or λ light chains]]
|[[Immunoglobulin G|IgG]]
| 10–15%
| Hematological diseases, particularly [[plasma cell dyscrasia#MGUS stage|MGUS]], [[plasma cell dyscrasia#Smoldering multiple myeloma stage|smoldering multiple myeloma]], [[multiple myeloma]], [[Waldenström's macroglobulinemia]], and [[B-cell chronic lymphocytic leukemia|chronic lymphocytic leukemia]]<ref name="pmid17289231">{{cite journal |vauthors = Tedeschi A, Baratè C, Minola E, Morra E |title = Cryoglobulinemia |journal = Blood Reviews |volume = 21 |issue = 4 |pages = 183–200 |year = 2007 |pmid = 17289231 |doi = 10.1016/j.blre.2006.12.002 |url = }}</ref>
|Various types, but usually monoclonal IgM plus polyclonal IgG (type II)<ref>{{cite journal |vauthors = Tedeschi A, Baratè C, Minola E, Morra E |title = Cryoglobulinemia |journal = Blood Reviews |volume = 21 |issue = 4 |pages = 183–200 |year = 2007 |pmid = 17289231 |doi = 10.1016/j.blre.2006.12.002 }}</ref>
|-
|-
|Typical antibody targets
| Type II
|[[Ii antigen system|I or i antigen]]
| Monoclonal IgM plus polyclonal IgG or, rarely, IgA
|[[P antigen system|P antigen]]
| 50–60%
|Other immunoglobulins
| Infectious diseases, particularly [[hepatitis C]] infection, [[HIV]] infection, and [[Hepatitis C and HIV coinfection]]; hematological diseases particularly B cell disorders; autoimmune diseases<ref name="pmid17289231" />
|-
|-
|Typical patients
| Type III
|Women over 70 years
| Polyclonal IgM plus polyclonal IgG or IgA
|Children
| 25–30%
|People over 60 years
| [[Autoimmune disease]]s, particularly [[Sjögren's syndrome]] and less commonly [[systemic lupus erythematosus]] and [[rheumatoid arthritis]]; infectious diseases particularly [[Hepatitis C virus|HCV]] infection<ref name="pmid17289231" />
|-
|Typical symptoms
|Anemia, acrocyanosis
|Dark urine, fever, chills, back or leg pain
|Palpable purpura, arthralgias, myalgias
|-
|[[Hemolysis]]
|Extravascular
|Intravascular
|No
|}
|}
Common features among the three conditions above include:

*All can trigger [[Raynaud's phenomenon]].<ref name="Gaddy p=468">{{cite journal | last=Gaddy | first=Clifford G. | title=Raynaud's Syndrome Associated with Idiopathic Cryoglobulinemia and Cold Agglutinins | journal=Archives of Internal Medicine | publisher=American Medical Association (AMA) | volume=102 | issue=3 | date=1958-09-01 | pages=468–77 | issn=0003-9926 | doi=10.1001/archinte.1958.00030010468020 | pmid=13570737 }}</ref><ref name="Mitchell Pergrum Gill 1974 pp. 113–5">{{cite journal | last1=Mitchell | first1=AB | last2=Pergrum | first2=GD | last3=Gill | first3=AM | title=Cold agglutinin disease with Raynaud's phenomenon. | journal=Proceedings of the Royal Society of Medicine | volume=67 | issue=2 | year=1974 | issn=0035-9157 | pmid=4544972 | pmc=1645247 | pages=113–5 | doi=10.1177/003591577406700212}}</ref><ref name="Antinuclear antibodies">{{cite journal| journal=Annals of the Rheumatic Diseases | date= 1982 | volume= 41 | issue= 4 | pages= 382–387 | title=Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies | author1=C. G. M. KALLENBERG |author2=G. W. PASTOOR |author3=A. A. WOUDA |author4=T. H. THE | url= | doi= 10.1136/ard.41.4.382 | pmid= 7051989 | pmc= 1000955 }}</ref><ref name="Lodi Resca Reverberi p.">{{cite journal | last1=Lodi | first1=Gianluca | last2=Resca | first2=Daniela | last3=Reverberi | first3=Roberto | title=Fatal cold agglutinin-induced haemolytic anaemia: a case report | journal=Journal of Medical Case Reports | publisher=Springer Nature | volume=4 | issue=1 | pages=252 | date=2010-08-06 | issn=1752-1947 | doi=10.1186/1752-1947-4-252 | pmid=20691050 | pmc=2923177 | doi-access=free }}</ref><ref name="Gertz pp. 19–23">{{cite journal | last=Gertz | first=M. A. | title=Cold Hemolytic Syndrome | journal=Hematology | publisher=American Society of Hematology | volume=2006 | issue=1 | date=2006-01-01 | issn=1520-4391 | doi=10.1182/asheducation-2006.1.19 | pmid=17124034 | pages=19–23| doi-access=free }}</ref><ref>{{cite journal| journal=Blood | title=Two Different Serologic Mechanisms of Paroxysmal Cold Hemoglobinuria, Illustrated by Three Cases | author1= J. J. VAN LOGHEM, Jn. |author2=E. MENDES DE LEON, M.D. |author3=HERTA FRENKEL-TIETZ |author4=IIA VAN DER HART | url=http://www.bloodjournal.org/content/bloodjournal/7/12/1196.full.pdf?sso-checked=true | archive-url=https://web.archive.org/web/20190214102320/http://www.bloodjournal.org/content/bloodjournal/7/12/1196.full.pdf?sso-checked=true | url-status=dead | archive-date=2019-02-14 | date=1952}}</ref>
{{further|Cryoglobulinemia#Classification}}
*All may be caused by infections, autoimmune disorders as well as lymphoma or other lymphoproliferative disorders.<ref name=UpToDate/>


===Complement===
===Complement===


[[Complement activation]] plays a definitive but limited role in warm-antibody AIHA (w-AIHA), whereas primary cold agglutinin disease (CAD), secondary cold agglutinin syndrome (CAS), and paroxysmal cold hemoglobinuria (PCH) are entirely complement-dependent disorders. <ref name="Berentsen Sundic 2015 pp. 1–11"/>
[[Complement activation]] plays a definitive but limited role in warm-antibody AIHA (w-AIHA), whereas primary cold agglutinin disease (CAD), secondary cold agglutinin syndrome (CAS), and paroxysmal cold hemoglobinuria (PCH) are entirely complement-dependent disorders.<ref name="Berentsen Sundic 2015 pp. 1–11"/>


===Hemolysis site===
==Reference==

Hemolysis induced by cold agglutinin disease taking place ''outside'' the vessels while which of Donath–Landsteiner antibodies is taking place ''inside'' the vessels.<ref name="Barcellini 2015 pp. 3–5"/><ref name="Medscape Reference 2019 on d-l"/>

==References==
{{reflist}}
{{reflist}}

{{Spleen}}


[[Category:Antibodies]]
[[Category:Antibodies]]

Latest revision as of 07:22, 3 December 2023

Cold sensitive antibodies
Other namesCold reactive antibodies, cold reacting antibodies
SpecialtyHematology

Cold sensitive antibodies (CSA) are antibodies sensitive to cold temperature. Some cold sensitive antibodies are pathological and can lead to blood disorder. These pathological cold sensitive antibodies include cold agglutinins, Donath–Landsteiner antibodies, and cryoglobulins which are the culprits of cold agglutinin disease, paroxysmal cold hemoglobinuria in the process of Donath–Landsteiner hemolytic anemia, and vasculitis, respectively.

Cold agglutinin antibodies[edit]

Cold agglutinins are antibodies, typically immunoglobulin M (IgM), that are acquainted with and then binding the antigens on red blood cells, typically antigens "I" or "i" on the RBC surface,[1] in the environment in which the temperatures are lower than normal core body temperature and, thus, ends up leading to agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels (extra-vessels), resulting in anemia without hemoglobinuria in ordinary cases.[2]

Cold agglutinins can cause two pathological conditions, that are, primary cold agglutinin disease (CAD)[3] and secondary cold agglutinin syndrome (CAS),[2] both of which are sole two subtypes of cold agglutinin disease.

Primary cold agglutinin disease is idiopathic, meaning the phenomenons of agglutinations of the red blood cells and hemolysis reaction occurring outside the vessels are absent from any underlying cause.[3] Nevertheless, what is known is, those with idiopathic cold agglutinin disease are susceptible to having or developing mild clonal bone marrow disorder.[3]

Secondary cold agglutinin syndrome refers to cold agglutinin disease that is identified to be caused by viral infection, autoimmune disorder, lymphoid malignancy, or any other underlying disease.[4]

Thermal amplitude[edit]

Cold agglutinins (CA) are autoantibodies that agglutinate RBCs with a temperature optimum of 3-4 °C but may also act in a warmer environment, depending on the thermal amplitude of the CA. If the thermal amplitude exceeds 28–30 °C, the CA will be pathogenic. Low-affinity CA also occurs in many healthy individuals; these nonpathogenic CA are polyclonal, have low thermal amplitude, and are present in low titers, not higher than 256 and usually lower than 64. More than 90% of pathogenic CA are of the IgM class and these IgM macromolecules can be pentameric or hexameric.[5]

Donath–Landsteiner antibodies[edit]

Donath–Landsteiner antibodies share similarities with cold agglutinin disease in recognition and connection of the antigens on the red blood cells' surface in the presence of relatively lower temperatures compared to core body temperature. Yet, the place where the hemolysis taking place differentiates between D-L antibodies and cold agglutinin.[6][7][8] D-L antibodies rather fix complement system which result in hemolysis in vessels (intra-vessels). Blood vessels are pathways carrying living-required elements to reach everywhere inside the body through circulation. This explains why the clinical manifestations of hemolysis caused by D-L antibodies are in line with representations of hemoglobinemia and hemoglobinuria. D-L antibodies, typically IgG, are characterized by targeting against red blood cells' on-surface antigens called "P".[9][10]

The pathophysiology of Donath–Landsteiner hemolytic anemia has been entitled as paroxysmal cold hemoglobinuria.[citation needed]

Cryoglobulins antibodies[edit]

Cryoglobulins are abnormal antibodies that only dissolve/disappear at temperature higher than 37 °C (99 °F) and form solid or gel-like immune complexes in presence of the environment under 37 °C (99 °F),[11][12] which can block blood vessels and cause a variety of health problems[12] including inflammation and organ damage.[13][14]

Many people affected by cryoglobulins will not experience any unusual signs or symptoms. When present, symptoms vary but may include breathing problems; fatigue; glomerulonephritis; joint pain or muscle pain; purpura; Raynaud's phenomenon; skin death; and/or skin ulcers. In some cases, the exact underlying cause is unknown; however, cryoglobulinemia can be associated with a variety of conditions including certain types of infection; chronic inflammatory diseases (such as autoimmune disease); and/or cancers of the blood or immune system. Treatment varies based on the severity of the condition, the symptoms present in each person and the underlying cause.[12]

At least 90% of cases having cryoglobulins in body, hepatitis C is to blame,[11][13] reflecting the importance of preclusion of hepatitis C.[11][13] The presence of cryoglobulins in body satisfies the criterion of the diagnosis of cryoglobulinemia, a disease that inflame the blood vessels and organs like kidney, nerves, joints, lungs and skin.[11] Normally, no cryoglobulins should be found in the body.[11]

Cryoglobulins more than often do not interact with red blood cells, unless it combines the features of cold agglutinin with cryoglobulins, although the chance is deemed rare. Therefore, cryoglobulins don't produce hemolysis effect, however its serious complications such as systemic inflammatory or neoplastic disorders can in turn lead to anemia.[13]

Comparisons between cold agglutinin, Donath–Landsteiner antibodies and cryoglobulin[edit]

Although there is some overlap of symptoms, cryoglobulinemia and cold agglutinin disease differ in the process by which blood vessels become blocked.[12] In cryoglobulinemia, antibodies accumulate and block blood vessels.[12][15] In cold agglutinin disease, antibodies (different from those in cryoglobulinemia) attack and kill red blood cells, which then accumulate and block blood vessels.[12][16]

Cold agglutinin antibodies[17] Donath–Landsteiner antibodies[17] Cryoglobulin[17]
Associated disease Cold agglutinin disease Paroxysmal cold hemoglobinuria Cryoglobulinemia[18]
Typical antibody types IgM IgG Various types, but usually monoclonal IgM plus polyclonal IgG (type II)[19]
Typical antibody targets I or i antigen P antigen Other immunoglobulins
Typical patients Women over 70 years Children People over 60 years
Typical symptoms Anemia, acrocyanosis Dark urine, fever, chills, back or leg pain Palpable purpura, arthralgias, myalgias
Hemolysis Extravascular Intravascular No

Common features among the three conditions above include:

Complement[edit]

Complement activation plays a definitive but limited role in warm-antibody AIHA (w-AIHA), whereas primary cold agglutinin disease (CAD), secondary cold agglutinin syndrome (CAS), and paroxysmal cold hemoglobinuria (PCH) are entirely complement-dependent disorders.[5]

Hemolysis site[edit]

Hemolysis induced by cold agglutinin disease taking place outside the vessels while which of Donath–Landsteiner antibodies is taking place inside the vessels.[10][9]

References[edit]

  1. ^ Pascual, V; Victor, K; Spellerberg, M; Hamblin, TJ; Stevenson, FK; Capra, JD (1992-10-01). "VH restriction among human cold agglutinins. The VH4-21 gene segment is required to encode anti-I and anti-i specificities". Journal of Immunology. 149 (7): 2337–44. doi:10.4049/jimmunol.149.7.2337. ISSN 0022-1767. PMID 1382098. S2CID 29186107.
  2. ^ a b Berentsen, Sigbjørn (2018-01-24). "How I manage patients with cold agglutinin disease". British Journal of Haematology. 181 (3). Wiley: 320–330. doi:10.1111/bjh.15109. ISSN 0007-1048. PMID 29363757.
  3. ^ a b c Małecka, Agnieszka; Trøen, Gunhild; Tierens, Anne; Østlie, Ingunn; Małecki, Jędrzej; Randen, Ulla; Wang, Junbai; Berentsen, Sigbjørn; Tjønnfjord, Geir E.; Delabie, Jan M. A. (19 December 2017). "Frequent somatic mutations of KMT 2D ( MLL 2 ) and CARD 11 genes in primary cold agglutinin disease". British Journal of Haematology. 183 (5). Wiley: 838–842. doi:10.1111/bjh.15063. ISSN 0007-1048. PMID 29265349.
  4. ^ Randen, U.; Troen, G.; Tierens, A.; Steen, C.; Warsame, A.; Beiske, K.; Tjonnfjord, G. E.; Berentsen, S.; Delabie, J. (18 October 2013). "Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma". Haematologica. 99 (3). Ferrata Storti Foundation (Haematologica): 497–504. doi:10.3324/haematol.2013.091702. ISSN 0390-6078. PMC 3943313. PMID 24143001.
  5. ^ a b Berentsen, Sigbjørn; Sundic, Tatjana (2015-01-29). "Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy". BioMed Research International. 2015. Hindawi Limited: 363278. doi:10.1155/2015/363278. ISSN 2314-6133. PMC 4326213. PMID 25705656.
  6. ^ Silberstein, LE; Berkman, EM; Schreiber, AD (1987). "Cold hemagglutinin disease associated with IgG cold-reactive antibody". Annals of Internal Medicine. 106 (2): 238–42. doi:10.7326/0003-4819-106-2-238. ISSN 0003-4819. PMID 3800184.
  7. ^ Rosse, WF; Adams, JP (1980). "The variability of hemolysis in the cold agglutinin syndrome". Blood. 56 (3): 409–16. doi:10.1182/blood.v56.3.409.bloodjournal563409. ISSN 0006-4971. PMID 7407408.
  8. ^ Zilow, G; Kirschfink, M; Roelcke, D (1994). "Red cell destruction in cold agglutinin disease". Infusionstherapie und Transfusionsmedizin. 21 (6): 410–5. doi:10.1159/000223021. ISSN 1019-8466. PMID 7873920.
  9. ^ a b Trisha Simone Tavares (2019-02-02). "Donath-Landsteiner Hemolytic Anemia: Practice Essentials, Pathophysiology, Etiology". Medscape Reference. Retrieved 2019-02-11.
  10. ^ a b Barcellini, W (2015), "Pitfalls in the diagnosis of autoimmune haemolytic anaemia.", Blood Transfusion = Trasfusione del Sangue, 13 (1): 3–5, doi:10.2450/2014.0252-14, ISSN 1723-2007, PMC 4317084, PMID 25636128
  11. ^ a b c d e "Cryoglobulins: MedlinePlus Medical Encyclopedia". MedlinePlus. 2019-01-28. Retrieved 2019-02-13.
  12. ^ a b c d e f "Cold agglutinin disease". Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. 2015-09-11. Archived from the original on 2019-03-30. Retrieved 2019-02-13.
  13. ^ a b c d Ferri, C; Zignego, AL; Pileri, SA (2002). "Cryoglobulins". Journal of Clinical Pathology. 55 (1): 4–13. doi:10.1136/jcp.55.1.4. PMC 1769573. PMID 11825916.
  14. ^ "Cryoglobulinemia". Cleveland Clinic. Retrieved 2019-02-13.
  15. ^ "Cryoglobulinemia: MedlinePlus Medical Encyclopedia". MedlinePlus. 2019-01-28. Retrieved 2019-02-13.
  16. ^ "Cold Agglutinin Disease: Practice Essentials, Pathophysiology, Etiology". Medscape Reference. 2019-02-02. Retrieved 2019-02-13.
  17. ^ a b c d "Comparison of paroxysmal cold hemoglobinuria, cold agglutinin disease, and cryoglobulinemia". UpToDate. Retrieved 2023-05-01.
  18. ^ Ferri C, Zignego AL, Pileri SA (2002). "Cryoglobulins". J. Clin. Pathol. 55 (1): 4–13. doi:10.1136/jcp.55.1.4. PMC 1769573. PMID 11825916.
  19. ^ Tedeschi A, Baratè C, Minola E, Morra E (2007). "Cryoglobulinemia". Blood Reviews. 21 (4): 183–200. doi:10.1016/j.blre.2006.12.002. PMID 17289231.
  20. ^ Gaddy, Clifford G. (1958-09-01). "Raynaud's Syndrome Associated with Idiopathic Cryoglobulinemia and Cold Agglutinins". Archives of Internal Medicine. 102 (3). American Medical Association (AMA): 468–77. doi:10.1001/archinte.1958.00030010468020. ISSN 0003-9926. PMID 13570737.
  21. ^ Mitchell, AB; Pergrum, GD; Gill, AM (1974). "Cold agglutinin disease with Raynaud's phenomenon". Proceedings of the Royal Society of Medicine. 67 (2): 113–5. doi:10.1177/003591577406700212. ISSN 0035-9157. PMC 1645247. PMID 4544972.
  22. ^ C. G. M. KALLENBERG; G. W. PASTOOR; A. A. WOUDA; T. H. THE (1982). "Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies". Annals of the Rheumatic Diseases. 41 (4): 382–387. doi:10.1136/ard.41.4.382. PMC 1000955. PMID 7051989.
  23. ^ Lodi, Gianluca; Resca, Daniela; Reverberi, Roberto (2010-08-06). "Fatal cold agglutinin-induced haemolytic anaemia: a case report". Journal of Medical Case Reports. 4 (1). Springer Nature: 252. doi:10.1186/1752-1947-4-252. ISSN 1752-1947. PMC 2923177. PMID 20691050.
  24. ^ Gertz, M. A. (2006-01-01). "Cold Hemolytic Syndrome". Hematology. 2006 (1). American Society of Hematology: 19–23. doi:10.1182/asheducation-2006.1.19. ISSN 1520-4391. PMID 17124034.
  25. ^ J. J. VAN LOGHEM, Jn.; E. MENDES DE LEON, M.D.; HERTA FRENKEL-TIETZ; IIA VAN DER HART (1952). "Two Different Serologic Mechanisms of Paroxysmal Cold Hemoglobinuria, Illustrated by Three Cases" (PDF). Blood. Archived from the original (PDF) on 2019-02-14.